Abstract
QUESTION: One of my epileptic patients takes carbamazepine. She is 36 weeks pregnant and has asked me whether she should start vitamin K to prevent neonatal bleeding. Does current evidence support this practice? ANSWER: Recent evidence does not support the notion that newborns of women treated with enzyme-inducing anticonvulsant drugs are at increased risk of hemorrhagic disease. Antenatal vitamin K can be prescribed on an individualized basis in certain circumstances, such as imminent premature delivery.
Original language | English |
---|---|
Pages (from-to) | 721-722 |
Number of pages | 2 |
Journal | Canadian Family Physician |
Volume | 52 |
Issue number | 6 |
State | Published - 2006 |
Externally published | Yes |